VX-11e

• Description:

  A potent, selective, and orally bioavailable inhibitor of ERK2 with Ki of <2 nM.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  500.3523

• Molecular Formula:

  C24H20Cl2FN5O2

• Notes:

  Research use only, not for human use.

• Receptor:

  AuroraA|CDK2|ERK2|FLT3|GSK-3

• CAS Number:

  896720-20-0